28-Sept-2026 20:54:06
NATCOPHARMIPO
NATCOPHARM : RIGHTS ISSUE OPENS SEPT 28, 2026
• Fund-raising committee approved the letter of offer for the rights issue. • Company obtained ISIN: INE987B20018 for credit of rights entitlements. • The meeting of the committee commenced at 8:15 p.m. and completed at 8:45 p.m. • The company is submitting the letter of offer to SEBI in compliance with securities and exchange board of india (issue of capital and disclosure requirements) regulations, 2018.
Natco Pharma Limited
Open attachment